Douglas Joseph Hirsch - 26 Oct 2025 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 Oct 2025, 17:54:30 UTC
Prior SEC filing
04 Jun 2025
Next SEC filing
05 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gracye Cheng, Attorney-in-Fact for Douglas Joseph Hirsch

Key filing fact

Douglas Joseph Hirsch filed Form 4 for GoodRx Holdings, Inc. (GDRX) on 27 Oct 2025.

Key facts

  • This page summarizes Douglas Joseph Hirsch's Form 4 filing for GoodRx Holdings, Inc. (GDRX).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 27 Oct 2025, 17:54.

Change

  • Previous filing in this sequence was filed on 04 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001822522 Primary reporting owner

Hirsch Douglas Joseph

Relationship
Director
Address
C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA
Signature
/s/ Gracye Cheng, Attorney-in-Fact for Douglas Joseph Hirsch
Signature date
27 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GDRX transaction

Class A Common Stock

Options Exercise

Transaction value
Shares
+20,521
Change %
+9.7%
Price
Shares after
231,909
Date
26 Oct 2025
Ownership
Direct
Footnotes
F1
GDRX holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,632,721
Date
26 Oct 2025
Ownership
By CH 2024-2 GRAT
Footnotes
F2
GDRX holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,632,721
Date
26 Oct 2025
Ownership
By DH 2024-2 GRAT
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GDRX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-20,521
Change %
-33%
Price
$0.000000
Shares after
41,042
Date
26 Oct 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
20,521
Exercise price
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Footnote F2

Share held directly by CH 2024-2 GRAT, a grantor retained annuity trust (the "CH 2024-2 GRAT"). Chona Hirsch, the Reporting Person's spouse, serves as the sole trustee and sole annuitant of the CH 2024-2 GRAT. The Reporting Person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the CH 2024-2 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares.

Footnote F3

Share held directly by DH 2024 -2 GRAT, a grantor retained annuity trust (the "DH 2024-2 GRAT"). The Reporting Person serves as the sole trustee and sole annuitant of the DH 2024-2 GRAT.

Footnote F4

The restricted stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on October 26, 2025, subject to continued service through the applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .